Nahuel Paesano, Violeta Catalá, Larisa Tcholakian, Xavier Alomar, Miguel Barranco, Enric Trilla, Juan Morote
{"title":"The effectiveness of mapping-targeted biopsies on the index lesion in transperineal prostate biopsies.","authors":"Nahuel Paesano, Violeta Catalá, Larisa Tcholakian, Xavier Alomar, Miguel Barranco, Enric Trilla, Juan Morote","doi":"10.1590/S1677-5538.IBJU.2023.0558","DOIUrl":"10.1590/S1677-5538.IBJU.2023.0558","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the effectiveness of mapping-targeted biopsies (MTB) on the index lesion for the detection of clinically significant prostate cancer (csPCa) in transperineal fusion-image prostate biopsies.</p><p><strong>Materials and methods: </strong>A retrospective analysis was conducted on 309 men with suspected PCa who underwent prostate biopsies at the Creu Blanca reference center in Barcelona, Spain. The Prostate Imaging-Reporting and Data System (PI-RADS v.2.1) of the magnetic resonance images (MRI) were reclassified by an expert radiologist reading of pre-biopsy biparametric MRI used for segmentation of suspected lesions. Transperineal MTB of suspicious lesions and 12-core systematic biopsies were performed using the Artemis™ platform. CsPCa was defined as International Society of Urological Pathology grade group ≥ 2.</p><p><strong>Results: </strong>CsPCa was detected in 192 men (62.1%), with detection rates of 6.3% for PI-RADS 2, 26.8% for PI-RADS 3, 87.3% for PI-RADS 4, and 93.1% for PI-RADS 5. MTB of the index lesion identified 185 csPCa (96.3%). CsPCa was detected solely in systematic biopsies in three cases (1.6%), while an additional four cases (2.1%) were identified only in the second suspected lesion. A predictive model for csPCa detection in MTB of the index lesion was developed, with an AUC of 0.918 (95% CI 0.887-0.950).</p><p><strong>Conclusions: </strong>This model had the potential to avoid 23.3% of prostate biopsies without missing additional csPCa cases. MTB of the index lesion was highly effective for identifying csPCa in fusion transperineal prostate biopsies. A developed predictive model successfully reduced the need for almost one quarter of biopsies without missing csPCa cases.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 ","pages":"296-308"},"PeriodicalIF":3.7,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11152324/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
José Agustin Cabrera Santa Cruz, Alexandre Danilovic, Fabio Carvalho Vicentini, Artur Henrique Brito, Carlos Alfredo Batagello, Giovanni Scalla Marchini, Fabio César Miranda Torricelli, William Carlos Nahas, Eduardo Mazzucchi
{"title":"Ureteral access sheath. Does it improve the results of flexible ureteroscopy? A narrative review.","authors":"José Agustin Cabrera Santa Cruz, Alexandre Danilovic, Fabio Carvalho Vicentini, Artur Henrique Brito, Carlos Alfredo Batagello, Giovanni Scalla Marchini, Fabio César Miranda Torricelli, William Carlos Nahas, Eduardo Mazzucchi","doi":"10.1590/S1677-5538.IBJU.2024.9907","DOIUrl":"10.1590/S1677-5538.IBJU.2024.9907","url":null,"abstract":"","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 ","pages":"346-358"},"PeriodicalIF":3.1,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11152322/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140159291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Guilherme Miranda Andrade, Felipe Giorgi Manente, Pedro José Damato Dias Barroso, Saulo Borborema Teles, Alexandre Dib Partezani, Willy Baccaglini, Rafael Sanchez-Salas, Ruben Olivares, Bruno Nahar, Gustavo Caserta Lemos, Bianca Bianco, Arie Carneiro
{"title":"Outcomes of ablative therapy and radical treatment for prostate cancer: a systematic review and meta-analysis.","authors":"Guilherme Miranda Andrade, Felipe Giorgi Manente, Pedro José Damato Dias Barroso, Saulo Borborema Teles, Alexandre Dib Partezani, Willy Baccaglini, Rafael Sanchez-Salas, Ruben Olivares, Bruno Nahar, Gustavo Caserta Lemos, Bianca Bianco, Arie Carneiro","doi":"10.1590/S1677-5538.IBJU.2023.0628","DOIUrl":"10.1590/S1677-5538.IBJU.2023.0628","url":null,"abstract":"<p><strong>Purpose: </strong>To compare biochemical recurrence, sexual potency and urinary continence outcomes of ablative therapy and radical treatment (radical prostatectomy or radiotherapy with androgen deprivation therapy).</p><p><strong>Material and methods: </strong>A systematic review and meta-analysis followed the PRISMA guidelines were performed. We searched MEDLINE/PubMed. Biochemical recurrence at three and five years; incontinence rate (patients who used one pad or more) and erectile dysfunction rate at 12 and 36 months (patients who did not have sufficient erection to achieve sexual intercourse) were evaluated. The Mantel-Haenszel method was applied to estimate the pooled risk difference (RD) in the individual studies for categorical variables. All results were presented as 95% confidence intervals (95%CI). Random effects models were used regardless of the level of heterogeneity (I²). (PROSPERO CRD42022296998).</p><p><strong>Results: </strong>Eight studies comprising 2,677 men with prostate cancer were included. There was no difference in biochemical recurrence between ablative and radical treatments. We observed the same biochemical recurrence between ablative therapy and radical treatment within five years (19.3% vs. 16.8%, respectively; RD 0.07; 95%CI=-0.05, 0.19; I2=68.2%; P=0.08) and continence rate at 12 months (9.2% vs. 31.8%, respectively; RD -0.13; 95%CI, -0.27, 0.01; I2=89%; P=0.32). When focal treatment was analyzed alone, two studies with 582 patients found higher erectile function at 12 months in the ablative therapy group than in the radical treatment (88.9% vs. 30.8%, respectively; RD -0.45; 95%CI -0.84, -0.05; I2=93%; P=0.03).</p><p><strong>Conclusion: </strong>Biochemical recurrence and urinary continence outcomes of ablative therapy and radical treatment were similar. Ablative therapy appears to have a high rate of sexual potency.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11152337/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hangcheng Fu, Laura Davis, Venkat Ramakrishnan, Thomas Barefoot, Colleen Sholtes, Lifan Liang, Mohammed Said, Jamie Messer
{"title":"Identify risk factors for perioperative outcomes in Intracorporeal Urinary Diversion and Extracorporeal Urinary Diversion with Robotic Cystectomy.","authors":"Hangcheng Fu, Laura Davis, Venkat Ramakrishnan, Thomas Barefoot, Colleen Sholtes, Lifan Liang, Mohammed Said, Jamie Messer","doi":"10.1590/S1677-5538.IBJU.2023.0477","DOIUrl":"10.1590/S1677-5538.IBJU.2023.0477","url":null,"abstract":"<p><strong>Introduction: </strong>The increasing adoption of robotic-assisted cystectomy with intracorporeal urinary diversion (ICUD), despite its complexity, prompts a detailed comparison with extracorporeal urinary diversion (ECUD). Our study at a single institution investigates perioperative outcomes and identifies risk factors impacting the success of these surgical approaches.</p><p><strong>Methods: </strong>In this retrospective analysis, 174 patients who underwent robotic-assisted cystectomy at the University of Louisville from June 2016 to August 2021 were reviewed. The cohort was divided into two groups based on the urinary diversion method: 30 patients underwent ECUD and 144 underwent ICUD. Data on demographics, complication rates, length of hospital stay, and readmission rates were meticulously collected and analyzed.</p><p><strong>Results: </strong>Operative times were comparable between the ICUD and ECUD groups. However, the ICUD group had a significantly lower intraoperative transfusion rate (0.5 vs. 1.0, p=0.02) and shorter hospital stay (7.8 vs. 12.3 days, p<0.001). Factors such as male sex, smoking history, diabetes mellitus, intravesical therapy, higher ASA, and ACCI scores were associated with increased Clavien-Dindo Grade 3 or higher complications. Age over 70 was the sole factor linked to a higher 90-day readmission rate, with no specific characteristics influencing the 30-day rate.</p><p><strong>Conclusion: </strong>Robotic cystectomy with ICUD results in shorter hospitalizations and lower intraoperative transfusion rates compared to ECUD, without differences in operative time, high-grade postoperative complications, or readmission rates. These findings can inform clinical decision-making, highlighting ICUD as a potentially more favorable option in appropriate settings.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 2","pages":"178-191"},"PeriodicalIF":3.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ana Raquel M Morais, Luciano A Favorito, Francisco J B Sampaio
{"title":"Kidney collecting system anatomy applied to endourology - a narrative review.","authors":"Ana Raquel M Morais, Luciano A Favorito, Francisco J B Sampaio","doi":"10.1590/S1677-5538.IBJU.2024.9901","DOIUrl":"10.1590/S1677-5538.IBJU.2024.9901","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the surgical anatomy of the kidney collecting system through a narrative review of the literature, highlighting its importance during diagnosis and its approach during surgical procedures for the treatment of renal stones.</p><p><strong>Material and methods: </strong>We carried out a review about the anatomy of the kidney collecting system. We analyzed papers published in the past 40 years in the databases Pubmed, Embase and Scielo, and we included only papers in English and excluded case reports, editorials and opinions of specialists.</p><p><strong>Results: </strong>Renal collecting system could be divided in four groups: A1 - kidney midzone (KM), drained by minor calyx that are dependent on the superior or the inferior caliceal groups; A2 - KM drained by crossed calyx, one draining into the superior caliceal group and another draining into the inferior caliceal group; B1 - KM drained by a major caliceal group independent of both the superior and inferior groups; and B2 - KM drained by minor calyx entering directly into the renal pelvis. Some details and anatomic variations of the collecting system are related to clinical and radiological aspects, particularly perpendicular calyces, interpyelocalyx space, position of calyces in relation to renal border, classification of the renal collecting system, infundibular diameter and the angle between the lower infundibulum and renal pelvis.</p><p><strong>Conclusion: </strong>The knowledge of intra-renal collecting system divisions and variations as the angle between the renal pelvis and lower infundibula, position of the calices in relationship with renal edge and the diameter and position of the calyces are important for the planning of minimally invasive renal surgeries.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 2","pages":"164-177"},"PeriodicalIF":3.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953598/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Thalita Bento Talizin, Alexandre Danilovic, Fabio Cesar Miranda Torricelli, Giovanni S Marchini, Carlos Batagello, Fabio C Vicentini, William Carlos Nahas, Eduardo Mazzucchi
{"title":"Postoperative antibiotic prophylaxis for percutaneous nephrolithotomy and risk of infection: a systematic review and meta-analysis.","authors":"Thalita Bento Talizin, Alexandre Danilovic, Fabio Cesar Miranda Torricelli, Giovanni S Marchini, Carlos Batagello, Fabio C Vicentini, William Carlos Nahas, Eduardo Mazzucchi","doi":"10.1590/S1677-5538.IBJU.2023.0626","DOIUrl":"10.1590/S1677-5538.IBJU.2023.0626","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study is to perform a high-quality meta-analysis using only randomized controlled trials (RCT) to better define the role of postoperative antibiotics in patients undergoing percutaneous nephrolithotomy (PCNL).</p><p><strong>Materials and methods: </strong>A literature search for RCTs in EMBASE, PubMed, and Web of Science up to May 2023 was conducted following the PICO framework: Population-adult patients who underwent PCNL; Intervention-postoperative antibiotic prophylaxis until nephrostomy tube withdrawal; Control-single dose of antibiotic during the induction of anesthesia; and Outcome-systemic inflammatory response syndrome (SIRS) or sepsis and fever after PCNL. The protocol was registered on the PROSPERO database (CRD42022361579). We calculated odds ratios (OR) and 95% confidence intervals (CI). A random-effects model was employed, and the alpha risk was defined as < 0.05.</p><p><strong>Results: </strong>Seven articles, encompassing a total of 629 patients, were included in the analysis. The outcome of SIRS or sepsis was extracted from six of the included studies, while the outcome of postoperative fever was extracted from four studies. The analysis revealed no statistical association between the use of postoperative antibiotic prophylaxis until nephrostomy tube withdrawal and the occurrence of SIRS/sepsis (OR 1.236, 95% CI 0.731 - 2.089, p=0.429) or fever (OR 2.049, 95% CI 0.790 - 5.316, p=0.140).</p><p><strong>Conclusion: </strong>Our findings suggest that there is no benefit associated with the use of postoperative antibiotic prophylaxis until nephrostomy tube withdrawal in patients undergoing percutaneous nephrolithotomy (PCNL). We recommend that antibiotic prophylaxis should be administered only until the induction of anesthesia in PCNL.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 2","pages":"152-163"},"PeriodicalIF":3.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953597/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Edoardo Beatrici, Muhieddine Labban, Dejan K Filipas, Benjamin V Stone, Leonardo O Reis, Filippo Dagnino, Giovanni Lughezzani, Nicolò M Buffi, Stuart R Lipsitz, Timothy N Clinton, Richard S Matulewicz, Quoc-Dien Trinh, Alexander P Cole
{"title":"Smoking characteristics and years since quitting smoking of US adults diagnosed with lung and bladder cancer: A national health and nutrition examination survey analysis.","authors":"Edoardo Beatrici, Muhieddine Labban, Dejan K Filipas, Benjamin V Stone, Leonardo O Reis, Filippo Dagnino, Giovanni Lughezzani, Nicolò M Buffi, Stuart R Lipsitz, Timothy N Clinton, Richard S Matulewicz, Quoc-Dien Trinh, Alexander P Cole","doi":"10.1590/S1677-5538.IBJU.2023.0625","DOIUrl":"10.1590/S1677-5538.IBJU.2023.0625","url":null,"abstract":"<p><strong>Purpose: </strong>Smoking is a recognized risk factor for bladder BC and lung cancer LC. We investigated the enduring risk of BC after smoking cessation using U.S. national survey data. Our analysis focused on comparing characteristics of LC and BC patients, emphasizing smoking status and the latency period from smoking cessation to cancer diagnosis in former smokers.</p><p><strong>Materials and methods: </strong>We analyzed data from the National Health and Examination Survey (2003-2016), identifying adults with LC or BC history. Smoking status (never, active, former) and the interval between quitting smoking and cancer diagnosis for former smokers were assessed. We reported descriptive statistics using frequencies and percentages for categorical variables and median with interquartile ranges (IQR) for continuous variables.</p><p><strong>Results: </strong>Among LC patients, 8.9% never smoked, 18.9% active smokers, and 72.2% former smokers. Former smokers had a median interval of 8 years (IQR 2-12) between quitting and LC diagnosis, with 88.3% quitting within 0-19 years before diagnosis. For BC patients, 26.8% never smoked, 22.4% were active smokers, and 50.8% former smokers. Former smokers had a median interval of 21 years (IQR 14-33) between quitting and BC diagnosis, with 49.3% quitting within 0-19 years before diagnosis.</p><p><strong>Conclusions: </strong>BC patients exhibit a prolonged latency period between smoking cessation and cancer diagnosis compared to LC patients. Despite smoking status evaluation in microhematuria, current risk stratification models for urothelial cancer do not incorporate it. Our findings emphasize the significance of long-term post-smoking cessation surveillance and advocate for integrating smoking history into future risk stratification guidelines.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 2","pages":"199-208"},"PeriodicalIF":3.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953605/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Melissa Faria Dutra, José de Bessa, Emerson Coelho Luiz de Almeida, Eleonora Moreira Lima, Mônica Maria de Almeida Vasconcelos, Flávia Cristina de Carvalho Mrad
{"title":"The effectiveness of parasacral transcutaneous electrical nerve stimulation in the treatment of monosymptomatic enuresis in children and adolescents: a systematic review.","authors":"Melissa Faria Dutra, José de Bessa, Emerson Coelho Luiz de Almeida, Eleonora Moreira Lima, Mônica Maria de Almeida Vasconcelos, Flávia Cristina de Carvalho Mrad","doi":"10.1590/S1677-5538.IBJU.2023.0618","DOIUrl":"10.1590/S1677-5538.IBJU.2023.0618","url":null,"abstract":"<p><strong>Background: </strong>Parasacral Transcutaneous Electrical Nerve Stimulation (PTENS) is a treatment used in enuresis refractory to first-line treatment. This review aimed to evaluate the effectiveness of PTENS in treating monosymptomatic enuresis (MNE) in children and adolescents.</p><p><strong>Methods: </strong>The study followed the Preferred Reporting Items for Systematic (PRISMA) guidelines. The search was carried out in the following databases: MEDLINE (via PubMed), Web of Science, SCOPUS, Central Cochrane Library and Physiotherapy Evidence Database (PEDro). The selected studies were randomized clinical trials (RCTs). The \"Risk of Bias tool for randomized trials\" and the \"Risk of Bias VISualization\" were used to analyze the risk of bias.</p><p><strong>Results: </strong>Of the 624 studies selected, four RCTs were eligible. Three included 146 children and adolescents aged between six and 16.3 years and used similar PTENS protocols with a frequency of 10 Hz, pulse duration of 700 µs and 20 minutes three times/week. One study enrolled 52 patients aged seven to 14 years used PTENS at home, with a pulse duration of 200 µs and 20 to 60 minutes twice/day. Risk of bias was observed in three studies due to results' randomization and measurement. Two studies showed a partial response with a reduction in wet nights, one a complete response in 27% of patients, and one showed no improvement.</p><p><strong>Conclusion: </strong>PTENS reduces wet nights' frequency but does not cure them, except in 27% of patients in one study. Limited RCTs and data heterogeneity are limitations.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 2","pages":"136-151"},"PeriodicalIF":3.1,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Felipe Placco Araujo Glina, Leonardo Lopes, Rodrigo Spinola E Silva, Eduardo Augusto Correa Barros, Bruno Biselli, Sidney Glina
{"title":"Do statins decrease testosterone in men? Systematic review and meta-analysis.","authors":"Felipe Placco Araujo Glina, Leonardo Lopes, Rodrigo Spinola E Silva, Eduardo Augusto Correa Barros, Bruno Biselli, Sidney Glina","doi":"10.1590/S1677-5538.IBJU.2023.0578","DOIUrl":"10.1590/S1677-5538.IBJU.2023.0578","url":null,"abstract":"<p><strong>Purpose: </strong>Statins are one of the most prescribed classes of drugs worldwide to treat hypercholesterolemia and dyslipidemia. By lowering the level of cholesterol, the use of statin could cause a reduction in testosterone levels. The objective was to evaluate whether the continued use of statins in patients with hypercholesterolemia causes a deficiency in testosterone and other sex hormones.</p><p><strong>Materials and methods: </strong>Systematic Review with Meta-analysis, performed in Embase, Medline and Cochrane databases, until May 2023; PROSPERO CRD42021270424protocol. Selection performed by two independent authors with subsequent conference in stages. Methodology based on PRISMA statement. There were selected comparative studies, prospective cohorts (CP), randomized clinical trials (RCT) and cross-sectional studies (CSS) with comparison of testosterone levels before and after statin administration and between groups. Bias analysis were evaluated with Cochrane Tool, The Newcastle-Ottawa Scale (NOS), and using the Assess the Quality of Cross-sectional studies (AXIS) tool.</p><p><strong>Results: </strong>There were found on MedLine, Embase and Cochrane, after selected comparative studies, 10CP and 6RCT and 6CSS for the meta-analysis. In the Forrest plot with 6CSS, a correlation between patients with continuous use of statins and a reduction in total testosterone was evidenced with a statistically significant reduction of 55.02ng/dL (95%CI=[39.40,70.64],I²=91%,p<0.00001).In the analysis with 5RCT, a reduction in the mean total testosterone in patients who started continuous statin use was evidenced, with a statistical significance of 13.12ng/dL (95%CI=[1.16,25.08],I²=0%,p=0.03). Furthermore, the analysis of all prospective studies with 15 articles showed a statistically significant reduction in the mean total testosterone of 9.11 ng/dL (95%CI=[0.16,18.06],I²=37%,p=0.04). A reduction in total testosterone has been shown in most studies and in its accumulated analysis after statin use. However, this decrease was not enough to reach levels below normal.</p><p><strong>Conclusion: </strong>Statins use causes a decrease in total testosterone, not enough to cause a drop below the normal range and also determines increase in FSH levels. No differences were found in LH, Estradiol, SHBG and Free Testosterone analysis.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 2","pages":"119-135"},"PeriodicalIF":3.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953607/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stefano Puliatti, Stefania Ferretti, Natali Rodriguez Peñaranda, Ahmed Eissa, Marco Ticonosco, Andrea De Faveri, Cosimo De Carne, Pawel Wisz, Riccardo Ferrari, Greta Tosi, Filippo Annino, Giampaolo Bianchi, Salvatore Micali
{"title":"Applicability and feasibility of robot-assisted cystectomy and intracorporeal urinary diversion in a patient with right renal pelvic ectopia.","authors":"Stefano Puliatti, Stefania Ferretti, Natali Rodriguez Peñaranda, Ahmed Eissa, Marco Ticonosco, Andrea De Faveri, Cosimo De Carne, Pawel Wisz, Riccardo Ferrari, Greta Tosi, Filippo Annino, Giampaolo Bianchi, Salvatore Micali","doi":"10.1590/S1677-5538.IBJU.2023.0608","DOIUrl":"10.1590/S1677-5538.IBJU.2023.0608","url":null,"abstract":"<p><strong>Background: </strong>The ectopic pelvic kidney, a common renal anomaly, is often smaller and malformed, with a shorter and sometimes tortuous ureter (1). Muscle-invasive bladder cancer (MIBC), constituting 15-25% of bladder cancer cases (2), mandates radical cystectomy with a 50% 5-year survival rate (2). Despite the growing use of robot-assisted radical cystectomy (RARC) (3, 4), there is limited data on its application in ectopic kidneys. Only one RARC case has been reported (5), in contrast to numerous open radical cystectomies (1, 6) involving an ectopic kidney.</p><p><strong>Patient and methods: </strong>After being diagnosed with T2 high-grade urothelial carcinoma, the 66-year-old patient, previously treated with multiple transurethral resections and adjuvant BCG therapy, received neoadjuvant chemotherapy. Preoperative staging CT revealed a 2.6 x 2.2 cm bladder neoformation and an ectopic right pelvic kidney.</p><p><strong>Results: </strong>Using the da Vinci Surgical System, radical cystectomy with ileal conduit (sec Wallace II) and lymphadenectomy were performed. During the demolition phase, the shorter right ureter was dissected with care to avoid damage to the renal pedicle. The reconstructive phase included intracorporeal urinary diversion (ICUD) and uretero-ileal anastomosis, facilitated by the favorable position of the kidney. The 8-hour console surgery resulted in minimal blood loss. Discharged on day 16 due to COVID-19, the patient exhibited positive outcomes. A 2-month CT follow-up revealed no cancer recurrence, metastasis, hydronephrosis, and complete regression of the lymphocele. Imaging follow-up continues without postoperative adjuvant chemotherapy.</p><p><strong>Conclusion: </strong>Robotic surgery with intracorporeal urinary diversion holds potential for right-sided pelvic kidney cases, but additional studies are necessary for validation.</p>","PeriodicalId":49283,"journal":{"name":"International Braz J Urol","volume":"50 2","pages":"227-228"},"PeriodicalIF":3.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10953599/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}